Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fina Climent

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
British Journal of Haematology|May 27, 2015
Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapySantiago Mercadal, Helena Pomares, Juan M Sancho, et al.
Histopathology|May 9, 2015
CD 30-positive transformed follicular lymphoma: two case reports and literature reviewSantiago Montes-Moreno, Fina Climent, Sonia González de Villambrosía, et al.
Virchows Archiv : an International Journal of Pathology|September 3, 2025
Skin manifestations uncover underlying Follicular helper T-cell lymphoma, angioimmunoblastic-type in an immunosuppressed patientMarie-Laure García, Rebeca Manso, Juan Torre Castro, et al.
British Journal of Haematology|May 24, 2020
Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experienceMaria Condom, Fina Climent, Davinia Fernández, et al.
Scientific Reports|October 9, 2024
Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trialBartomeu Fullana, Serafín Morales, Anna Petit, et al.
Frontiers in Oncology|October 11, 2019
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single InstitutionSonia Pernas, Anna Petit, Fina Climent, et al.
Frontiers in Oncology|August 27, 2019
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single InstitutionSonia Pernas, Anna Petit, Fina Climent, et al.
Journal of the American Academy of Dermatology|June 26, 2013
Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patientsOctavio Servitje, Cristina Muniesa, Yolanda Benavente, et al.
The Journal of Investigative Dermatology|November 19, 2014
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphomaJuan Sandoval, Angel Díaz-Lagares, Rocío Salgado, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2024
Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular InsightsMing Liang Oon, Jing Quan Lim, Jan Bosch-Schips, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|May 27, 2015
Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapySantiago Mercadal, Helena Pomares, Juan M Sancho, et al.
Histopathology|May 9, 2015
CD 30-positive transformed follicular lymphoma: two case reports and literature reviewSantiago Montes-Moreno, Fina Climent, Sonia González de Villambrosía, et al.
Virchows Archiv : an International Journal of Pathology|September 3, 2025
Skin manifestations uncover underlying Follicular helper T-cell lymphoma, angioimmunoblastic-type in an immunosuppressed patientMarie-Laure García, Rebeca Manso, Juan Torre Castro, et al.
British Journal of Haematology|May 24, 2020
Clonal relationship in multisited mucosa-associated lymphoid tissue lymphomas: a single-centre experienceMaria Condom, Fina Climent, Davinia Fernández, et al.
Scientific Reports|October 9, 2024
Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trialBartomeu Fullana, Serafín Morales, Anna Petit, et al.
Frontiers in Oncology|October 11, 2019
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single InstitutionSonia Pernas, Anna Petit, Fina Climent, et al.
Frontiers in Oncology|August 27, 2019
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single InstitutionSonia Pernas, Anna Petit, Fina Climent, et al.
Journal of the American Academy of Dermatology|June 26, 2013
Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patientsOctavio Servitje, Cristina Muniesa, Yolanda Benavente, et al.
The Journal of Investigative Dermatology|November 19, 2014
MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphomaJuan Sandoval, Angel Díaz-Lagares, Rocío Salgado, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2024
Characterizing Nodal Gamma-Delta T-Cell Lymphoma: Clinicopathological and Molecular InsightsMing Liang Oon, Jing Quan Lim, Jan Bosch-Schips, et al.
Pageof 9